News

Filter

Current filters:

Dermatologicals

1 to 9 of 199 results

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

Latest approval for Novartis’ Cosentyx, from US FDA

Latest approval for Novartis’ Cosentyx, from US FDA

22-01-2015

Adding to recent marketing clearances in Japan and the European Union, the US Food and Drug Administration…

BiotechnologyCosentyxDermatologicalsNovartisRegulationUSA

Novartis’ Cosentyx gets third approval, now in Europe

19-01-2015

The European Commission (EC) has approved Swiss pharma giant Novartis’ Cosentyx (secukinumab, formerly…

BiotechnologyCosentyxDermatologicalsEuropeNovartisRegulation

Celgene’s oral Otezla approved by EC for psoriasis and psoriatic arthritis

Celgene’s oral Otezla approved by EC for psoriasis and psoriatic arthritis

18-01-2015

US biotech firm Celgene’s European subsidiary has received marketing authorization from the European…

Anti-Arthritics/RheumaticsBiotechnologyCelgene CorpDermatologicalsEuropeOtezlaRegulation

Ferrer licenses Canadian rights for ozenoxacin to Cipher Pharma

07-01-2015

Privately-held Spanish pharmaceutical company Ferrer says it has licensed commercialization rights for…

CanadaCipher PharmaceuticalsDermatologicalsFerrerLicensingOzenoxacinPharmaceutical

Leo Pharma files for US approval of first aerosol foam for psoriasis

06-01-2015

Independent Danish dermatology specialist Leo Pharma has submitted a New Drug Application to the US Food…

BetamethasonecalcipotrienecalcipotriolDermatologicalsLEO PharmaPharmaceuticalRegulationUSA

Chugai wins first round of patent infringement law suit for Oxarol ointment

Chugai wins first round of patent infringement law suit for Oxarol ointment

29-12-2014

Japanese drugmaker Chugai Pharmaceutical says that, on December 24, the Tokyo District Court granted…

Cerbios-PharmaChugai PharmaceuticalDermatologicalsDKSHGenericsIwaki SeiyakuJapanLegalOxarolPatentsPola PharmaRocheTakata Seiyaku

First ever regulatory approval of Novartis' Cosentyx, in Japan

First ever regulatory approval of Novartis' Cosentyx, in Japan

26-12-2014

The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Swiss pharma giant Novartis’…

Anti-Arthritics/RheumaticsBiotechnologyCosentyxDermatologicalsJapanNovartisRegulation

1 to 9 of 199 results

COMPANY SPOTLIGHT

Menarini

Back to top